X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (155584) 155584
Book Review (23573) 23573
Publication (8308) 8308
Conference Proceeding (330) 330
Newsletter (222) 222
Book / eBook (204) 204
Book Chapter (123) 123
Magazine Article (114) 114
Dissertation (57) 57
Transcript (52) 52
Newspaper Article (46) 46
Paper (7) 7
Web Resource (7) 7
Data Set (6) 6
Trade Publication Article (6) 6
Presentation (3) 3
Reference (3) 3
Report (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (149381) 149381
index medicus (145963) 145963
antineoplastic combined chemotherapy protocols - therapeutic use (104040) 104040
female (94362) 94362
male (77794) 77794
middle aged (71320) 71320
oncology (70947) 70947
adult (59293) 59293
aged (58198) 58198
chemotherapy (44151) 44151
treatment outcome (36179) 36179
cancer (35719) 35719
antineoplastic combined chemotherapy protocols - adverse effects (30011) 30011
combined modality therapy (28593) 28593
prognosis (22885) 22885
antineoplastic combined chemotherapy protocols - administration & dosage (21158) 21158
neoplasm staging (20321) 20321
cisplatin - administration & dosage (20043) 20043
hematology (17303) 17303
aged, 80 and over (16690) 16690
adolescent (16425) 16425
survival rate (16294) 16294
animals (15858) 15858
disease-free survival (15725) 15725
fluorouracil - administration & dosage (15698) 15698
retrospective studies (15463) 15463
antineoplastic agents - therapeutic use (15373) 15373
care and treatment (15328) 15328
therapy (15184) 15184
breast neoplasms - drug therapy (14663) 14663
doxorubicin - administration & dosage (14588) 14588
cyclophosphamide - administration & dosage (14133) 14133
follow-up studies (13517) 13517
survival analysis (13407) 13407
lung neoplasms - drug therapy (13043) 13043
drug administration schedule (12971) 12971
survival (12388) 12388
chemotherapy, adjuvant (12349) 12349
cisplatin (12014) 12014
child (11399) 11399
medicine & public health (11267) 11267
abridged index medicus (11251) 11251
remission induction (10920) 10920
surgery (10393) 10393
radiotherapy (10267) 10267
carcinoma (10208) 10208
vincristine - administration & dosage (10065) 10065
cell line, tumor (9989) 9989
research (9893) 9893
mice (9656) 9656
analysis (9279) 9279
pharmacology & pharmacy (9279) 9279
tumors (9062) 9062
breast cancer (8894) 8894
trial (8846) 8846
time factors (8704) 8704
dose-response relationship, drug (8649) 8649
antineoplastic agents - administration & dosage (8536) 8536
antineoplastic agents (8395) 8395
breast neoplasms - pathology (8184) 8184
deoxycytidine - analogs & derivatives (8123) 8123
etoposide - administration & dosage (8083) 8083
child, preschool (8032) 8032
hematology, oncology and palliative medicine (7988) 7988
prospective studies (7881) 7881
health aspects (7722) 7722
apoptosis (7649) 7649
paclitaxel - administration & dosage (7552) 7552
antimitotic agents (7492) 7492
carcinoma, non-small-cell lung - drug therapy (7488) 7488
metastasis (7470) 7470
antineoplastic agents - pharmacology (7401) 7401
adenocarcinoma - drug therapy (7191) 7191
clinical trials as topic (7188) 7188
antineoplastic combined chemotherapy protocols - pharmacology (7172) 7172
neoplasm metastasis (7097) 7097
young adult (7054) 7054
risk factors (6972) 6972
drug therapy (6966) 6966
neoplasms - drug therapy (6625) 6625
deoxycytidine - administration & dosage (6527) 6527
carboplatin - administration & dosage (6521) 6521
methotrexate - administration & dosage (6440) 6440
paclitaxel (6218) 6218
expression (6217) 6217
recurrence (6076) 6076
antineoplastic combined chemotherapy protocols (6073) 6073
apoptosis - drug effects (5996) 5996
lung neoplasms - pathology (5982) 5982
doxorubicin (5878) 5878
antineoplastic agents - adverse effects (5844) 5844
combination (5781) 5781
neoadjuvant therapy (5773) 5773
colorectal neoplasms - drug therapy (5749) 5749
prednisone - administration & dosage (5745) 5745
ovarian neoplasms - drug therapy (5739) 5739
cyclophosphamide (5704) 5704
clinical trials (5668) 5668
fluorouracil (5631) 5631
disease progression (5572) 5572
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (150) 150
Collection Dvlpm't (Acquisitions) - Vendor file (13) 13
Online Resources - Online (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (6) 6
Chemistry (A D Allen) - Stacks (2) 2
Gerstein Science - Circulation Desk (2) 2
Credit Valley Hospital - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Sunnybrook Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Oshawa (1) 1
UTL at Downsview - May be requested (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (135308) 135308
Japanese (9011) 9011
French (2544) 2544
German (2471) 2471
Chinese (2277) 2277
Russian (1344) 1344
Spanish (914) 914
Italian (628) 628
Polish (624) 624
Hungarian (291) 291
Dutch (160) 160
Czech (122) 122
Danish (68) 68
Portuguese (60) 60
Romanian (60) 60
Ukrainian (59) 59
Hebrew (53) 53
Korean (45) 45
Bulgarian (43) 43
Serbian (39) 39
Croatian (31) 31
Finnish (31) 31
Norwegian (29) 29
Swedish (20) 20
Turkish (16) 16
Slovak (13) 13
Bosnian (10) 10
Lithuanian (8) 8
Afrikaans (2) 2
Manx (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2009, Current clinical oncology, ISBN 9781603270861, xxviii, 637
A panel of international authorities analyzes in depth in this book the role of the lymphovascular system in the spread of cancer. They also summarize the... 
Neoplasms Invasiveness | Neoplasm Metastasis | Clinical & internal medicine | Metastasis | Lymphangiogenesis - drug effects | Pathology | Oncology | Medicine & Public Health | Radiotherapy | Surgical Oncology
Book
2007, ISBN 9780195187762, ix, 355
Book
JAMA, ISSN 0098-7484, 06/2017, Volume 317, Issue 23, pp. 2392 - 2401
IMPORTANCE: Combining biologic monoclonal antibodies with chemotherapeutic cytotoxic drugs provides clinical benefit to patients with advanced or metastatic... 
MEDICINE, GENERAL & INTERNAL | LEUCOVORIN | FIRE-3 | THERAPY | FOLFIRI PLUS CETUXIMAB | PHASE-II | IRINOTECAN | OXALIPLATIN | FLUOROURACIL | TUMORS | PROGRESSION | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Bevacizumab - therapeutic use | United States | Bevacizumab - adverse effects | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Cetuximab - therapeutic use | Cetuximab - adverse effects | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Camptothecin - administration & dosage | Female | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Kaplan-Meier Estimate | Treatment Outcome | Canada | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colorectal Neoplasms - secondary | Aged | Genes, ras | Organoplatinum Compounds - adverse effects | Chemotherapy | Usage | Care and treatment | Research | Colorectal cancer | Cancer | Drugs | Medical research | Colorectal carcinoma | Clinical trials | Cytotoxicity | Patients | Survival | K-Ras protein | Bevacizumab | Metastases | Survival analysis | Irinotecan | Randomization | Oxaliplatin | Monoclonal antibodies | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 22, pp. 2078 - 2092
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 19, pp. 1823 - 1833
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 990 - 998
Summary Background Optimum management strategies for patients with advanced non-small-cell lung cancer (NSCLC) with acquired resistance to EGFR tyrosine-kinase... 
Hematology, Oncology and Palliative Medicine | TYROSINE KINASE INHIBITORS | MULTICENTER | ONCOLOGY | ADENOCARCINOMA | ACQUIRED-RESISTANCE | OPEN-LABEL | AFATINIB | ERLOTINIB | GEMCITABINE | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Prospective Studies | Guanine - analogs & derivatives | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Cisplatin - administration & dosage | Receptor, Epidermal Growth Factor - metabolism | Time Factors | Adult | Female | Quinazolines - administration & dosage | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Genetic Predisposition to Disease | Lung Neoplasms - enzymology | Drug Administration Schedule | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - mortality | Pemetrexed | Disease Progression | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Phenotype | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Asia | Glutamates - administration & dosage | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Biomarkers, Tumor - genetics | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Infusions, Intravenous | Mutation | Guanine - administration & dosage | Medical colleges | Chemotherapy | Strategic planning (Business) | Genetic aspects | Product development | Lung cancer, Non-small cell | Gefitinib | Cancer | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 1, pp. 23 - 34
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 2, pp. 138 - 148
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2015, Volume 373, Issue 13, pp. 1270 - 1271
To the Editor: I found the results of the CheckMate 067 study reported by Larkin and colleagues (July 2 issue) 1 to be extremely encouraging. Like many... 
MEDICINE, GENERAL & INTERNAL | Skin Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Melanoma - drug therapy | Antibodies, Monoclonal - therapeutic use | Female | Male | Melanoma | Index Medicus | Abridged Index Medicus
Journal Article